Drug Profile
HCT 6015
Alternative Names: Nitroketorolac; NO-ketorolacLatest Information Update: 03 Oct 2002
Price :
$50
*
At a glance
- Originator NicOx
- Class Antirheumatics; Indoles; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain; Rheumatic disorders
Most Recent Events
- 03 Oct 2002 Discontinued - Preclinical for Pain (unspecified route)
- 03 Oct 2002 Discontinued - Preclinical for Rheumatic disorders (PO)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed